• 3M Begins Manufacturing Authorized Generic of PROVENTIL® HFA (albuterol sulfate) Inhaler Offering a New Option for Patients to Lower Their Medication Costs

    April 17, 2019

    • ST. Paul, Minn – (April 17, 2019) – 3M has announced that it is manufacturing an authorized generic of PROVENTIL® HFA (albuterol sulfate) Inhalation Aerosol in the U.S., which will be distributed by Par Pharmaceutical (Par) an operating company of Endo International plc.. The product will be manufactured by 3M Drug Delivery Systems (DDS).


       “3M Drug Delivery Systems is proud to work with Par to offer patients a lower list price treatment option,” said Keith O’Connor, 3M DDS Global Business Leader.


      “We have a long history of putting patients first,” said Silvia Perez, 3M DDS President and General Manager. “As generics continue to change the landscape of the pharmaceutical industry, we are committed to using our broad expertise to help our partners navigate the complex process of bringing a generic inhalation product to pharmacies across the country.”


       For more information about the new authorized generic from Par Pharmaceutical, please visit www.parpharm.com.


      3M is a trademark of 3M Company.